Kathleen Beusterien

9PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesAudiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 16, 2025
Patient preferences for treatment pathways in early-stage breast cancer: application of a discrete choice experiment.

Christian Jackisch, Chikako Shimizu, Emuella Flood

|Jul 21, 2023
A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiative.

Tanya Collin-Histed, Madeline Stoodley, Kathleen Beusterien

|Mar 07, 2022
Benefit-risk trade-offs in treatment choice in advanced HER2 negative breast cancer: patient and oncologist perspectives.

Suvina Amin, Sara M Tolaney, M Janelle Cambron-Mellott

|Dec 08, 2021
Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer.

Rebecca L Stone, M Janelle Cambron-Mellott, Kathleen Beusterien

Pageof 2